AYTU BioPharma
AYTU
29 hedge funds and large institutions have $3.19M invested in AYTU BioPharma in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
21% more funds holding
Funds holding: 24 → 29 (+5)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
2.72% less ownership
Funds ownership: 33.31% → 30.58% (-2.7%)
34% less capital invested
Capital invested by funds: $4.81M → $3.19M (-$1.62M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$21.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.2K |
| 3 |
Millennium Management
New York
|
+$18.9K |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$6.53K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$171K |
| 2 |
AC
Armistice Capital
New York
|
-$157K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$34.2K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$19.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NA
26
NewEdge Advisors
New Orleans,
Louisiana
| $36 | – | – | – |
|
|
SIC
27
SJS Investment Consulting
Sylvania,
Ohio
| $9 | – | – | – |
|
28
Credit Agricole
Montrouge Cedex,
France
| $9 | +$9 | +5 | New |
|
|
29
Northern Trust
Chicago,
Illinois
| – | -$34.2K | -14,557 | Closed |
|
|
CWM
30
CarsonAllaria Wealth Management
Glen Carbon,
Illinois
| – | -$12 | -5 | Closed |
|
AYTU Hedge Fund Activity: Q4 2024 in Review
29 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2024, worth a combined $3.19M — down 34% from $4.81M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AYTU positions and 2 closed out — a net gain of 5 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $21.4K. The largest seller was Stonepine Capital Management, cutting an estimated $171K.
- 29 institutional investors held AYTU BioPharma (AYTU) as of Q4 2024, up from 24 in Q3 2024.
- Funds reported $3.19M of AYTU BioPharma stock for Q4 2024, down 34% quarter-over-quarter.
- 7 funds opened new AYTU BioPharma positions in Q4 2024 and 2 closed out, a net change of +5 holders.
- The largest AYTU BioPharma buyer in Q4 2024 was Two Sigma Securities, an estimated $21.4K added.
- The largest AYTU BioPharma seller in Q4 2024 was Stonepine Capital Management, an estimated $171K sold.
Based on aggregated 13F filings for Q4 2024.